A massive study of medical and genetic data shows that people with a particular version of a gene involved in immune response had a lower risk of Alzheimer’s and Parkinson’s disease.
Scientists at Oregon’s only public academic health center (OHSU) have discovered a new avenue of cell death in Alzheimer’s disease and vascular dementia.
A neuroradiologist at the Mayo Clinic in Jacksonville, FL warns that increased use of monoclonal antibody treatment for Alzheimer’s has also led to the discovery of amyloid-related imaging abnormalities — ARIA. Find out more.
Tau PET is an imaging test used to detect the presence of tau protein in the brain. Researchers say it’s the best way to predict the rate of cognitive decline due to Alzheimer’s.
Researchers at UCI found that breathing in aromas while sleeping sparks a 226% cognitive increase.
Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day.
The future of millions at risk for dementia could change with the use of hearing aids. Learn more.
Dr. Robert Przybelski has prescribed lecanemab to real-life patients, and discusses his experience prescribing and administering the treatment.
Now, a third new Alzheimer’s drug expected to be approved by the Food and Drug Administration (FDA),. The field of new drugs is beginning to show progress in the fight to slow the disease.
The FDA has approved generic lecanemab (brand name Leqembi®). The new drug can slow the progression of Alzheimer’s. Two top doctors discuss the pros and cons.
New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.
Strengthening social connections may offer a surprising boost to long-term brain health.
When Memory Loss Becomes Invisible to Those Who Need Help Most
It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.
